This relationship is vital for the success of immunotherapy-based treatments which, despite their curative potential, currently only work in between 20 and 40% of patients," explains Dr. Anna ...
Abstract and Introduction Personalized Evasion Mechanisms Epigenetic Therapy & its Implication in Personalized Immunotherapy Conclusion References Although some neoplasms are associated with ...
Dr. Catherine Wu discussed the unique aspects of clear cell renal cell carcinoma and the challenges of targeting it with a ...
The Global Cancer Immunotherapy Market achieved a valuation of $121.2 Billion in 2023 and is anticipated to exceed $245.37 ...
Researchers discovered that gut microbiota-derived hexa-acylated LPS enhances the effectiveness of anti-PD-1 cancer ...